Bioavailability of oral curcumin.
作者信息
Garg Amit X, Moist Louise, Pannu Neesh, Tobe Sheldon, Walsh Michael, Weir Matthew
机构信息
Professor, Departments of Medicine and of Epidemiology and Biostatistics, Western University, London, Ont.
Professor, Department of Medicine, University of Alberta, Edmonton, Alta.
出版信息
CMAJ. 2019 Apr 15;191(15):E428. doi: 10.1503/cmaj.71719.
Abstract
摘要
相似文献
1
Bioavailability of oral curcumin.口服姜黄素的生物利用度。
CMAJ. 2019 Apr 15;191(15):E428. doi: 10.1503/cmaj.71719.
2
What about bioavailability of oral curcumin?口服姜黄素的生物利用度如何？
CMAJ. 2019 Apr 15;191(15):E427. doi: 10.1503/cmaj.71708.
3
Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement.胺功能化立方介孔硅纳米粒子作为一种口服递送系统，用于提高姜黄素的生物利用度。
Nanotechnology. 2016 Dec 16;27(50):505605. doi: 10.1088/0957-4484/27/50/505605. Epub 2016 Nov 22.
4
Oral bioavailability of curcumin: problems and advancements.姜黄素的口服生物利用度：问题与进展
J Drug Target. 2016 Sep;24(8):694-702. doi: 10.3109/1061186X.2016.1157883. Epub 2016 Mar 17.
5
Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles.载姜黄素半乳糖化白蛋白纳米粒的肠吸收机制与药代动力学评价。
Int J Nanomedicine. 2019 Dec 10;14:9721-9730. doi: 10.2147/IJN.S229992. eCollection 2019.
6
Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.使用固体脂质纳米粒增强姜黄素的口服生物利用度。
Food Chem. 2020 Jan 1;302:125328. doi: 10.1016/j.foodchem.2019.125328. Epub 2019 Aug 3.
7
Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.用于姜黄素口服递送的固体脂质纳米粒的表面修饰：通过增强细胞摄取和淋巴摄取提高生物利用度。
Eur J Pharm Biopharm. 2017 Aug;117:132-140. doi: 10.1016/j.ejpb.2017.04.013. Epub 2017 Apr 12.
8
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.探索固体脂质纳米粒以提高姜黄素的口服生物利用度。
Mol Nutr Food Res. 2011 Mar;55(3):495-503. doi: 10.1002/mnfr.201000310. Epub 2010 Oct 11.
9
Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.口服给药后聚（乳酸-乙醇酸）基姜黄素纳米颗粒的代谢命运。
Int J Nanomedicine. 2016 Jun 28;11:3009-22. doi: 10.2147/IJN.S107442. eCollection 2016.
10
Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.负载姜黄素的固体脂质纳米粒与Brij78和TPGS共同作用提高了姜黄素的体内口服生物利用度和原位肠道吸收。
Drug Deliv. 2016;23(2):459-70. doi: 10.3109/10717544.2014.918677. Epub 2014 Jun 3.
引用本文的文献
1
Curcumin-encapsulated exosomes in bisphosphonate-modified hydrogel microspheres promote bone repair through macrophage polarization and DNA damage mitigation.双膦酸盐修饰的水凝胶微球中包裹姜黄素的外泌体通过巨噬细胞极化和减轻DNA损伤促进骨修复。
Mater Today Bio. 2025 May 15;32:101874. doi: 10.1016/j.mtbio.2025.101874. eCollection 2025 Jun.
2
An enzyme-mimicking reactive oxygen species scavenger targeting oxidative stress-inflammation cycle ameliorates IR-AKI by inhibiting pyruvate dehydrogenase kinase 4.一种靶向氧化应激-炎症循环的模拟酶活性氧清除剂通过抑制丙酮酸脱氢酶激酶4改善缺血再灌注急性肾损伤。
Theranostics. 2024 Nov 4;14(19):7534-7553. doi: 10.7150/thno.101229. eCollection 2024.
3
Recent advances in anti-inflammation via AMPK activation.通过激活AMPK实现抗炎作用的最新进展。
Heliyon. 2024 Jun 26;10(13):e33670. doi: 10.1016/j.heliyon.2024.e33670. eCollection 2024 Jul 15.
4
Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus.基于网络药理学的三七和黄精治疗糖尿病靶点预测策略
World J Clin Cases. 2022 Jul 16;10(20):6900-6914. doi: 10.12998/wjcc.v10.i20.6900.
5
Multiple Mechanisms of Shenqi Pill in Treating Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接探讨参芪丸治疗非酒精性脂肪性肝病的多重机制
Evid Based Complement Alternat Med. 2022 Jun 26;2022:2384140. doi: 10.1155/2022/2384140. eCollection 2022.
6
Cytotoxic, Genotoxic and Senolytic Potential of Native and Micellar Curcumin.天然姜黄素和胶束姜黄素的细胞毒性、遗传毒性和衰老细胞溶解作用。
Nutrients. 2021 Jul 13;13(7):2385. doi: 10.3390/nu13072385.
7
Network pharmacology-based strategy for predicting therapy targets of Tripterygium wilfordii on acute myeloid leukemia.基于网络药理学的方法预测雷公藤治疗急性髓系白血病的作用靶点。
Medicine (Baltimore). 2020 Dec 11;99(50):e23546. doi: 10.1097/MD.0000000000023546.
本文引用的文献
1
What about bioavailability of oral curcumin?口服姜黄素的生物利用度如何？
CMAJ. 2019 Apr 15;191(15):E427. doi: 10.1503/cmaj.71708.
2
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial.用于治疗慢性肾脏病的微粒姜黄素-1：一项多中心临床试验的研究方案
Can J Kidney Health Dis. 2018 Dec 5;5:2054358118813088. doi: 10.1177/2054358118813088. eCollection 2018.
3
Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial.口服姜黄素在择期腹主动脉瘤修复中的应用：一项多中心随机对照试验。
CMAJ. 2018 Oct 29;190(43):E1273-E1280. doi: 10.1503/cmaj.180510.
4
Therapeutic roles of curcumin: lessons learned from clinical trials.姜黄素的治疗作用：临床试验获得的经验。
AAPS J. 2013 Jan;15(1):195-218. doi: 10.1208/s12248-012-9432-8. Epub 2012 Nov 10.
5
Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting.姜黄素类对冠状动脉旁路移植术后急性心肌梗死发生率的影响。
Am J Cardiol. 2012 Jul 1;110(1):40-4. doi: 10.1016/j.amjcard.2012.02.043. Epub 2012 Apr 3.
6
Metabolism of curcumin--studies with [3H]curcumin.姜黄素的代谢——用[3H]姜黄素进行的研究
Toxicology. 1981;22(4):337-44. doi: 10.1016/0300-483x(81)90027-5.
Zotero 插件